MARKET

ANAB

ANAB

Anaptysbio Inc
NASDAQ
25.78
-0.88
-3.30%
After Hours: 25.26 -0.52 -2.02% 16:50 02/03 EST
OPEN
26.48
PREV CLOSE
26.66
HIGH
26.88
LOW
25.77
VOLUME
158.84K
TURNOVER
0
52 WEEK HIGH
32.44
52 WEEK LOW
18.20
MARKET CAP
732.97M
P/E (TTM)
-5.3391
1D
5D
1M
3M
1Y
5Y
AnaptysBio rises 10% on stock repurchase of up to $50M
Seeking Alpha · 01/13 14:39
AnaptysBio Announces Stock Repurchase Plan Of Up To $50M Of The Company's Outstanding Common Stock
Benzinga · 01/13 14:01
AnaptysBio Approves $50 Million Share Buyback Plan; Stock Gains
AnaptysBio Approves $50 Million Share Buyback Plan; Stock Gains
MT Newswires · 01/13 09:39
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
TANH, HKD and NXTP among mid-day movers
Seeking Alpha · 01/06 17:45
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 01/06 17:30
Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday
Benzinga · 01/06 16:17
CVAC and ZYXI among healthcare movers
Seeking Alpha · 01/06 15:53
More
About ANAB
AnaptysBio, Inc. is a clinical-stage biotechnology company developing immunology therapeutic product. The Company is focused on the immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops products using antibody discovery technology platform, which is based upon a natural process of antibody generation, known as somatic hypermutation, and replicates this natural process of antibody generation in vitro. Its advanced antibody programs include: Imsidolimab is an antibody that inhibits the interleukin-36 receptor, for the treatment of inflammatory diseases called generalized pustular psoriasis and hidradenitis suppurativa; Rosnilimab is an anti-PD-1 agonist antibody program, is designed to augment PD-1 signaling through Rosnilimab treatment to suppress T-cell driven human inflammatory diseases; anti-BTLA modulator antibody, known as ANB032, is applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation.

Webull offers kinds of AnaptysBio Inc stock information, including NASDAQ:ANAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANAB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANAB stock methods without spending real money on the virtual paper trading platform.